Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 13/20 | 0.49 |
| ▸ | RIOK2 | Q9BVS4 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29652162 | 1.00 | KCNH2 (0.49) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL3424094 | 1.00 | KCNH2 (0.49) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL1057997 | 1.00 | KCNH2 (0.49) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL3173642 | 0.99 | KCNH2 (0.48) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL3173652 | 0.99 | KCNH2 (0.48) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL6212285 | 0.99 | KCNH2 (0.48) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL4207580 | 0.99 | KCNH2 (0.48) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL3173648 | 0.91 | KCNH2 (0.41) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL4207578 | 0.91 | KCNH2 (0.41) | KCNH2RIOK2KDM4EALDH1A1POLB | |
| SCHEMBL29743296 | 0.91 | KCNH2 (0.41) | KCNH2RIOK2KDM4EALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100340-A1 | REDUCTION OF INFLUENCE OF HEMOGLOBIN IN MEASUREMENT OF ZINC IN BIOLOGICAL SAMPLE | 日東紡績株式会社 | 2026-05-15 | — | — | WO | claimed |
| EP-4244385-B1 | LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT | MULTIPLEXDX S R O (SK) | 2025-01-01 | — | — | EP | claimed |
| CN-116802315-A | Loop-mediated isothermal nucleic acid amplification (LAMP) using LNA modified primers and metal-based colorimetric detection of amplified products | 马尔提普莱克斯公司 | 2023-09-22 | — | — | CN | claimed |
| EP-4244385-A1 | LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT | MultiplexDX, s.r.o. (SK) | 2023-09-20 | — | — | EP | claimed |
| WO-2023076772-A1 | COMPOSITIONS AND METHODS FOR DETECTING PYROPHOSPHATE PRODUCTS OF ENZYME REACTIONS USING PYRIDYLAZOANILINE DYES | NEW ENGLAND BIOLABS, INC. (US) | 2023-05-04 | — | — | WO | claimed |
| WO-2022101259-A1 | LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT | MultiplexDX, s.r.o. (SK) | 2022-05-19 | — | — | WO | claimed |
| WO-2026100340-A1 | REDUCTION OF INFLUENCE OF HEMOGLOBIN IN MEASUREMENT OF ZINC IN BIOLOGICAL SAMPLE | 日東紡績株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-12536631-B2 | System and method for enhancing visualization of colorimetric assay readouts | DOMUS DIAGNOSTICS, INC. (US) | 2026-01-27 | — | — | US | disclosed |
| US-20250382666-A1 | ASSAY DEVICE FOR ISOTHERMAL AMPLIFICATION AND DETECTION OF NUCLEIC ACIDS | DOMUS DIAGNOSTICS, INC. | 2025-12-18 | — | — | US | disclosed |
| WO-2024264054-A2 | SYSTEM AND METHOD FOR ENHANCING VISUALIZATION OF COLORIMETRIC ASSAY READOUTS | DOMUS DIAGNOSTICS, INC. (US) | 2024-12-26 | — | — | WO | disclosed |
| US-20240428386-A1 | SYSTEM AND METHOD FOR ENHANCING VISUALIZATION OF COLORIMETRIC ASSAY READOUTS | DOMUS DIAGNOSTICS, INC. | 2024-12-26 | — | — | US | disclosed |
| CN-116802315-A | Loop-mediated isothermal nucleic acid amplification (LAMP) using LNA modified primers and metal-based colorimetric detection of amplified products | 马尔提普莱克斯公司 | 2023-09-22 | — | — | CN | disclosed |
| EP-4244385-A1 | LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT | MultiplexDX, s.r.o. (SK) | 2023-09-20 | — | — | EP | disclosed |
| WO-2023076772-A1 | COMPOSITIONS AND METHODS FOR DETECTING PYROPHOSPHATE PRODUCTS OF ENZYME REACTIONS USING PYRIDYLAZOANILINE DYES | NEW ENGLAND BIOLABS, INC. (US) | 2023-05-04 | — | — | WO | disclosed |
| WO-2022101259-A1 | LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT | MultiplexDX, s.r.o. (SK) | 2022-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12536631-B2 | System and method for enhancing visualization of colorimetric assay readouts | NR2E3, PDE6C, PDE6H | KCNH2 4067/4885RIOK2 4847/4885KDM4E 4415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.